Big data reveals treatment trends for early puberty in chinese kids
NCT ID NCT05341128
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at medical records of 1,477 children in China diagnosed with central precocious puberty (early puberty). The goal was to see how many received treatment and how well it worked. No new treatments were tested—researchers simply collected existing information to understand current care patterns.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
1,477 people
The number who actually took part.
- Started
-
Dec 2023
- Finished
-
Aug 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Pediatric participants with a diagnosis of CPP who are currently or previously undergoing GnRHa treatment between 2015 and 31 December 2024 will be enrolled in this study.
- Ages
-
Up to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: • Participants diagnosed with CPP and treated with GnRHa from the centers participating in this study within the Chinese CPP Big Data Platform database since 2015 to 2024. CPP diagnosis is based on the clinical assessment and description by CPP specialized doctors. Exclusion Criteria: * Not received GnRHa as the treatment for CPP. * No available data for analysis.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Central precocious puberty are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hainan Women and Children's Medical Center
Haikou, Hainan, 570206, China
-
Shandong Provincial Hospital Affiliated to Shandong First Medical University
Jinan, Shandong, 250021, China
-
The Second Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, 530007, China
-
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, 300052, China
-
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
Wuhan, Hubei, 430030, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.